SCHEMBL23319005

SCHEMBL23319005

c1ccc(-c2nc(-c3ccccc3)nc(-c3c(-c4ccc(-n5c6ccccc6c6ccccc65)cc4)ccc4ccccc34)n2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 4/20 0.44
▸ ATM Q13315 3/20 0.44
▸ KDM4E B2RXH2 2/20 0.44
▸ MAPT P10636 3/20 0.35
▸ SMN1; SMN2 Q16637 2/20 0.35
▸ NPC1 O15118 1/20 0.35
▸ LMNA P02545 1/20 0.35
▸ RECQL P46063 1/20 0.35
▸ RAB9A P51151 1/20 0.35
▸ KMT2A Q03164 3/20 0.35
▸ HDAC4 P56524 1/20 0.35
▸ ALDH1A1 P00352 2/20 0.34
▸ MEN1 O00255 2/20 0.34
▸ TP53 P04637 1/20 0.34
▸ HPGD P15428 1/20 0.34
▸ TSHR P16473 1/20 0.34
▸ NFKB1 P19838 1/20 0.34
▸ MAPK1 P28482 1/20 0.34
▸ NFKB2 Q00653 1/20 0.34
▸ RELA Q04206 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25679966 0.96 ATM (0.41) L3MBTL1ATMKDM4EMAPTSMN1; SMN2
SCHEMBL22639494 0.95 L3MBTL1 (0.44) L3MBTL1ATMKDM4EMAPTSMN1; SMN2
SCHEMBL22639426 0.94 ATM (0.42) L3MBTL1ATMKDM4EMAPTSMN1; SMN2
SCHEMBL20404895 0.93 KDM4E (0.38) L3MBTL1ATMKDM4EMAPTSMN1; SMN2
SCHEMBL18819235 0.92 KDM4E (0.36) L3MBTL1ATMKDM4EMAPTSMN1; SMN2
SCHEMBL18819234 0.92 ATM (0.36) L3MBTL1ATMKDM4EMAPTSMN1; SMN2
SCHEMBL18819388 0.91 L3MBTL1 (0.41) L3MBTL1ATMKDM4EMAPTSMN1; SMN2
SCHEMBL22639390 0.90 KDM4E (0.40) L3MBTL1ATMKDM4EMAPTSMN1; SMN2
SCHEMBL22639382 0.89 ATM (0.39) L3MBTL1ATMKDM4EMAPTSMN1; SMN2
SCHEMBL25679991 0.89 KDM4E (0.39) L3MBTL1ATMKDM4EMAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220407012-A1 ORGANIC COMPOUND, ORGANIC LIGHT-EMITTING DIODE INCLUDING ORGANIC COMPOUND, AND DISPLAY DEVICE INCLUDING ORGANIC LIGHT-EMITTING DIODE SOULBRAIN CO., LTD. (KR) 2022-12-22 — — US disclosed
WO-2021086143-A1 ORGANIC COMPOUND, ORGANIC LIGHT-EMITTING DIODE COMPRISING SAME, AND DISPLAY DEVICE COMPRISING ORGANIC LIGHT-EMITTING DIODE 솔브레인 주식회사 2021-05-06 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220407012-A1 ORGANIC COMPOUND, ORGANIC LIGHT-EMITTING DIODE INCLUDING ORGANIC COMPOUND, AND DISPLAY DEVICE INCLUDING ORGANIC LIGHT-EMITTING DIODE OCIAD1, AOX1, OXER1 L3MBTL1 113/4885ATM 3796/4885KDM4E 2915/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback